Table 3.
Univariate and multivariable analyses.
| Univariate | Multivariable | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p-Value | OR | 95% CI | p-Value | |
| Age | 1.08 | 1.06–1.11 | <0.0001 | 1.04 | 0.99–1.08 | 0.054 |
| LM-LAD versus others | 0.89 | 0.57–1.37 | 0.59 | |||
| MVD | 1.49 | 0.92–2.42 | 0.10 | 1.42 | 0.85–2.37 | 0.18 |
| Gender | 0.79 | 0.48–1.30 | 0.35 | |||
| BMI | 0.99 | 0.98–1.01 | 0.21 | |||
| Hypertension | 2.46 | 1.30–4.67 | 0.006 | 1.59 | 0.81–3.15 | 0.18 |
| Dyslipidemia | 1.23 | 0.77–1.94 | 0.39 | |||
| Smoking status: | ||||||
| Current | 1.29 | 0.81–2.04 | 0.29 | |||
| Former | 0.90 | 0.49–1.63 | 0.72 | |||
| Diabetes | 1.74 | 1.12–2.69 | 0.014 | |||
| Previous MI | 1.29 | 0.81–2.04 | 0.28 | |||
| IHD | 1.01 | 0.65–1.56 | 0.97 | |||
| COPD | 2.23 | 1.10–4.50 | 0.026 | |||
| PAD | 1.58 | 2.35–5.47 | 0.039 | 0.38 | 0.18–0.79 | 0.01 |
| CKD | 3.59 | 2.35–5.47 | <0.0001 | 1.37 | 1.02–2.94 | 0.04 |
| Previous stroke/TIA | 1.45 | 0.61–3.47 | 0.40 | |||
| LVEF | 0.95 | 0.93–0.97 | <0.0001 | 0.97 | 0.95–0.99 | 0.003 |
| Proximal disease | 1.20 | 0.78–1.84 | 0.41 | |||
| % DS | 1.01 | 0.99–1.03 | 0.43 | |||
| De novo vs. other | 0.53 | 0.29–0.99 | 0.047 | 0.57 | 0.30–1.11 | 0.10 |
| Functional SS-2020 | 1.03 | 1.02–1.03 | <0.0001 | 1.02 | 1.01–1.04 | 0.027 |
OR: odds ratio; CI: confident interval; LM: left main; LAD: left anterior descendant; MVD: multivessel disease; BMI: body mass index; MI: myocardial infarction; PAD: peripheral vascular disease; IHD: ischemic heart disease; COPD: chronic obstructive pulmonary disease; TIA: transient ischemic attack; LVEF: left ventricle ejection fraction; DS: diameter of stenosis; SS: syntax score.